• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Insight Molecular Diagnostics Inc. - Common Stock (NQ:IMDX)

    4.200 +0.220 (+5.53%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Insight Molecular Diagnostics Inc. - Common Stock

    News headline image
    Transcript: Insight Molecular Q2 2026 Earnings Conference Call ↗
    Insight Molecular (NASDAQ:IMDX) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings... 
    Via Benzinga
    Topics Earnings
    News headline image
    Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript ↗
    FDA review nears completion as reimbursement rates support commercial launch. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Oncocyte Eyes Faster, Less Invasive Heart Transplant Rejection Testing ↗
    Insight Molecular Diagnostics discussed the potential use of donor-derived cell-free DNA testing in heart transplant surveillance during a virtual session featuring transplant cardiologist Dr. Max... 
    Via MarketBeat
    News headline image
    Oncocyte Q2 Earnings Call Highlights ↗
    Oncocyte (NASDAQ:IMDX) executives said they continue to target FDA marketing authorization for the GraftAssureDx kidney-transplant rejection test later this year, while preparing for a commercial... 
    Via MarketBeat
    Topics Earnings
    Insight Molecular Diagnostics (NASDAQ:IMDX) Soars on 285% Revenue Beat and Key FDA Submission ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
     
    Via Benzinga
    News headline image
    Exploring Insight Molecular's Earnings Expectations ↗
     
    Via Benzinga
    News headline image
    IMDX Q1 2026 Earnings Call Transcript ↗
    IMDX Q1 2026 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    These stocks are moving in today's session ↗
    Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report. 
    Via Chartmill
    Topics Artificial Intelligence
    News headline image
    INSIGHT MOLECULAR DIAGNOSTIC (NASDAQ:IMDX) Stock Plummets 11.8% on Q3 Earnings Miss ↗
    Insight Molecular Dx (IMDX) stock fell 11.8% after missing Q3 2025 revenue and EPS estimates. The company remains focused on its FDA submission for the GraftAssureDx™ test. 
    Via Chartmill
    News headline image
    A Look at Insight Molecular's Upcoming Earnings Report ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For August 11, 2025 ↗
     
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.